| A01AA |
Caries prophylactic agents
|
Agents prophylactiques des caries
|
WHO |
Active |
2021-06-14 14:58:44 |
| A01AA01 |
sodium fluoride
|
Fluorure de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A01AA02 |
sodium monofluorophosphate
|
monofluorophosphate de sodium
|
WHO |
Active |
2023-01-25 11:26:57 |
| A01AA03 |
olaflur
|
olaflur
|
WHO |
Active |
2023-01-25 11:27:42 |
| A01AA04 |
stannous fluoride
|
Fluorure d'étain
|
WHO |
Active |
2021-06-09 15:34:07 |
| A01AA30 |
combinations
|
associations
|
WHO |
Active |
2023-01-25 11:28:25 |
| A01AA51 |
sodium fluoride, combinations
|
fluorure de sodium, associations
|
WHO |
Active |
2023-01-25 11:29:09 |
| A01AB |
Antiinfectives and antiseptics for local oral treatment
|
Anti-infectieux et antiseptiques pour un traitement local oral
|
WHO |
Active |
2021-06-09 15:34:07 |
| A01AB02 |
hydrogen peroxide
|
Peroxyde d'hydrogène
|
WHO |
Active |
2021-06-09 15:34:07 |
| A01AB03 |
chlorhexidine
|
Chlorhexidine
|
WHO |
Active |
2021-06-09 15:34:07 |
| A01AB04 |
amphotericin B
|
Amphotéricine b
|
WHO |
Active |
2021-06-09 15:34:07 |
| A01AB05 |
polynoxylin
|
polynoxylin
|
WHO |
Active |
2023-01-25 11:29:50 |
| A01AB06 |
domiphen
|
domiphen
|
WHO |
Active |
2023-01-25 11:30:33 |
| A01AB07 |
oxyquinoline
|
Oxyquinoline
|
WHO |
Active |
2021-06-09 15:34:07 |
| A01AB08 |
neomycin
|
Néomycine
|
WHO |
Active |
2021-06-09 15:34:07 |
| A01AB09 |
miconazole
|
Miconazole
|
WHO |
Active |
2021-06-09 15:34:07 |
| A01AB10 |
natamycin
|
natamycine
|
WHO |
Active |
2023-01-25 11:31:16 |
| A01AB12 |
hexetidine
|
hexétidine
|
WHO |
Active |
2023-01-25 11:31:58 |
| A01AB13 |
tetracycline
|
tétracycline
|
WHO |
Active |
2023-01-25 11:32:42 |
| A01AB14 |
benzoxonium chloride
|
chlorure de benzoxonium
|
WHO |
Active |
2023-01-25 11:33:23 |
| A01AB15 |
tibezonium iodide
|
iodure de tibezonium
|
WHO |
Active |
2023-01-25 11:34:06 |
| A01AB16 |
mepartricin
|
mépartricine
|
WHO |
Active |
2023-01-25 11:34:48 |
| A01AB17 |
metronidazole
|
Métronidazole
|
WHO |
Active |
2021-06-09 15:34:07 |
| A01AB18 |
clotrimazole
|
Clotrimazole
|
WHO |
Active |
2021-06-09 15:34:07 |
| A01AB19 |
sodium perborate
|
perborate de sodium
|
WHO |
Active |
2023-01-25 11:59:27 |
| A01AB21 |
chlortetracycline
|
Chlortétracycline
|
WHO |
Active |
2021-06-09 15:34:07 |
| A01AB22 |
doxycycline
|
Doxycycline
|
WHO |
Active |
2021-06-09 15:34:07 |
| A01AB23 |
minocycline
|
Minocycline
|
WHO |
Active |
2021-06-09 15:34:07 |
| A01AC |
Corticosteroids for local oral treatment
|
Corticostéroïdes pour un traitement local oral
|
WHO |
Active |
2021-06-09 15:34:07 |
| A01AC01 |
triamcinolone
|
triamcinolone
|
WHO |
Active |
2023-01-25 12:00:09 |
| A01AC02 |
dexamethasone
|
Dexaméthasone
|
WHO |
Active |
2021-06-09 15:34:07 |
| A01AC03 |
hydrocortisone
|
Hydrocortisone
|
WHO |
Active |
2021-06-09 15:34:07 |
| A01AC54 |
prednisolone, combinations
|
prednisolone, associations
|
WHO |
Active |
2023-01-25 12:00:51 |
| A01AD |
Other agents for local oral treatment
|
Autres agents pour un traitement local oral
|
WHO |
Active |
2021-06-09 15:34:07 |
| A01AD01 |
epinephrine
|
Épinéphrine
|
WHO |
Active |
2021-06-09 15:34:07 |
| A01AD02 |
benzydamine
|
benzydamine
|
WHO |
Active |
2023-01-25 12:01:35 |
| A01AD05 |
acetylsalicylic acid
|
Acide acétylsalicylique
|
WHO |
Active |
2021-06-09 15:34:07 |
| A01AD06 |
adrenalone
|
adrénalone
|
WHO |
Active |
2023-01-25 12:02:17 |
| A01AD07 |
amlexanox
|
amlexanox
|
WHO |
Active |
2023-01-25 12:03:00 |
| A01AD08 |
becaplermin
|
bécaplermine
|
WHO |
Active |
2023-01-25 12:03:43 |
| A02AA |
Magnesium compounds
|
Dérivés du magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A02AA01 |
magnesium carbonate
|
Carbonate de magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A02AA02 |
magnesium oxide
|
Oxyde de magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A02AA03 |
magnesium peroxide
|
peroxyde de magnésium
|
WHO |
Active |
2023-01-25 12:04:28 |
| A02AA04 |
magnesium hydroxide
|
Hydroxyde de magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A02AA05 |
magnesium silicate
|
silicate de magnésium
|
WHO |
Active |
2023-01-25 12:05:12 |
| A02AA10 |
combinations
|
associations
|
WHO |
Active |
2023-01-25 12:05:56 |
| A02AB |
Aluminium compounds
|
Dérivés de l'aluminium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A02AB01 |
aluminium hydroxide
|
hydroxyde d'aluminium
|
WHO |
Active |
2023-01-25 12:06:41 |
| A02AB02 |
algeldrate
|
algeldrate
|
WHO |
Active |
2023-01-25 12:07:26 |
| A02AB03 |
aluminium phosphate
|
phosphate d'aluminium
|
WHO |
Active |
2023-01-25 12:08:08 |
| A02AB04 |
dihydroxialumini sodium carbonate
|
carbonate sodique dihydroxialuminique
|
WHO |
Active |
2023-01-27 09:29:04 |
| A02AB05 |
aluminium acetoacetate
|
acétoacétate d'aluminium
|
WHO |
Active |
2023-01-27 09:29:49 |
| A02AB06 |
aloglutamol
|
aloglutamol
|
WHO |
Active |
2023-01-27 09:30:30 |
| A02AB07 |
aluminium glycinate
|
glycinate d'aluminium
|
WHO |
Active |
2023-01-27 09:31:14 |
| A02AB10 |
combinations
|
associations
|
WHO |
Active |
2023-01-27 09:31:55 |
| A02AC |
Calcium compounds
|
Dérivés du calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A02AC01 |
calcium carbonate
|
Carbonate de calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A02AC02 |
calcium silicate
|
silicate de calcium
|
WHO |
Active |
2023-01-27 09:32:38 |
| A02AC10 |
combinations
|
associations
|
WHO |
Active |
2023-01-27 09:33:19 |
| A02AD |
Combinations and complexes of aluminium, calcium and magnesium compounds
|
Associations et dérivés complexes d'aluminium, de calcium et de magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A02AD01 |
ordinary salt combinations
|
associations ordinaires de sels
|
WHO |
Active |
2023-01-27 09:34:01 |
| A02AD02 |
magaldrate
|
magaldrate
|
WHO |
Active |
2023-01-27 09:34:43 |
| A02AD03 |
almagate
|
almagate
|
WHO |
Active |
2023-01-27 09:35:27 |
| A02AD04 |
hydrotalcite
|
hydrotalcite
|
WHO |
Active |
2023-01-27 09:36:09 |
| A02AD05 |
almasilate
|
almasilate
|
WHO |
Active |
2023-01-27 09:36:52 |
| A02AF |
Antacids with antiflatulents
|
Antacides et antiflatulents
|
WHO |
Active |
2021-06-09 15:34:07 |
| A02AF01 |
magaldrate and antiflatulents
|
magaldrate et antiflatulents
|
WHO |
Active |
2023-01-27 09:37:35 |
| A02AF02 |
ordinary salt combinations and antiflatulents
|
associations ordinaires de sels et antiflatulents
|
WHO |
Active |
2023-01-27 09:38:17 |
| A02BA |
H2-receptor antagonists
|
Antihistaminiques anti-H2
|
WHO |
Active |
2021-06-09 15:34:07 |
| A02BA01 |
cimetidine
|
Cimétidine
|
WHO |
Active |
2021-06-09 15:34:07 |
| A02BA02 |
ranitidine
|
Rantidine
|
WHO |
Active |
2021-06-09 15:34:07 |
| A02BA03 |
famotidine
|
Famotidine
|
WHO |
Active |
2021-06-09 15:34:07 |
| A02BA04 |
nizatidine
|
Nizatidine
|
WHO |
Active |
2021-06-09 15:34:07 |
| A02BA05 |
niperotidine
|
nipérotidine
|
WHO |
Active |
2023-01-27 09:39:01 |
| A02BA06 |
roxatidine
|
roxatidine
|
WHO |
Active |
2023-01-27 09:39:46 |
| A02BA07 |
ranitidine bismuth citrate
|
ranitidine bismuth citrate
|
WHO |
Active |
2023-01-27 09:40:28 |
| A02BA08 |
lafutidine
|
lafutidine
|
WHO |
Active |
2023-01-27 09:41:09 |
| A02BA51 |
cimetidine, combinations
|
cimétidine, associations
|
WHO |
Active |
2023-01-27 09:41:53 |
| A02BA53 |
famotidine, combinations
|
famotidine, associations
|
WHO |
Active |
2023-01-27 09:42:35 |
| A02BB |
Prostaglandins
|
Prostaglandines
|
WHO |
Active |
2021-06-09 15:34:07 |
| A02BB01 |
misoprostol
|
Misoprostol
|
WHO |
Active |
2021-06-09 15:34:07 |
| A02BB02 |
enprostil
|
enprostil
|
WHO |
Active |
2023-01-27 09:43:20 |
| A02BC |
Proton pump inhibitors
|
Inhibiteurs de la pompe à protons
|
WHO |
Active |
2021-06-09 15:34:07 |
| A02BC01 |
omeprazole
|
Oméprazole
|
WHO |
Active |
2021-06-09 15:34:07 |
| A02BC02 |
pantoprazole
|
Pantoprazole
|
WHO |
Active |
2021-06-09 15:34:07 |
| A02BC03 |
lansoprazole
|
Lansoprazole
|
WHO |
Active |
2021-06-09 15:34:07 |
| A02BC04 |
rabeprazole
|
rabéprazole
|
WHO |
Active |
2023-01-27 09:44:02 |
| A02BC05 |
esomeprazole
|
Ésoméprazole
|
WHO |
Active |
2021-06-09 15:34:07 |
| A02BC06 |
dexlansoprazole
|
Dexlansoprazole
|
WHO |
Active |
2021-06-09 15:34:07 |
| A02BC07 |
dexrabeprazole
|
dexrabéprazole
|
WHO |
Active |
2023-01-27 09:44:43 |
| A02BC08 |
vonoprazan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A02BC53 |
lansoprazole, combinations
|
lansoprazole, associations
|
WHO |
Active |
2023-01-27 09:45:25 |
| A02BC54 |
rabeprazole, combinations
|
rabéprazole, associations
|
WHO |
Active |
2023-01-27 09:46:06 |
| A02BD |
Combinations for eradication of Helicobacter pylori
|
Associations pour l'éradication du Helicobacter pylori
|
WHO |
Active |
2021-06-09 15:34:07 |
| A02BD01 |
omeprazole, amoxicillin and metronidazole
|
oméprazole, amoxicilline et métronidazole
|
WHO |
Active |
2023-01-27 11:41:30 |
| A02BD02 |
lansoprazole, tetracycline and metronidazole
|
lansoprazole, tétracycline et métronidazole
|
WHO |
Active |
2023-01-27 11:42:14 |
| A02BD03 |
lansoprazole, amoxicillin and metronidazole
|
lansoprazole, amoxicilline et métronidazole
|
WHO |
Active |
2023-01-27 11:42:57 |
| A02BD04 |
pantoprazole, amoxicillin and clarithromycin
|
pantoprazole, amoxicilline et clarithromycine
|
WHO |
Active |
2023-01-27 11:43:39 |
| A02BD05 |
omeprazole, amoxicillin and clarithromycin
|
oméprazole, amoxicilline et clarithromycine
|
WHO |
Active |
2023-01-27 11:44:21 |
| A02BD06 |
esomeprazole, amoxicillin and clarithromycin
|
ésoméprazole, amoxicilline et clarithromycine
|
WHO |
Active |
2023-01-27 11:45:04 |
| A02BD07 |
lansoprazole, amoxicillin and clarithromycin
|
lansoprazole, amoxicilline et clarithromycine
|
WHO |
Active |
2023-01-27 11:45:45 |
| A02BD08 |
bismuth subcitrate, tetracycline and metronidazole
|
subcitrate de bismuth, tétracycline et métronidazole
|
WHO |
Active |
2023-01-27 11:46:27 |
| A02BD09 |
lansoprazole, clarithromycin and tinidazole
|
lansoprazole, clarithromycine et tinidazole
|
WHO |
Active |
2023-01-27 11:47:09 |
| A02BD10 |
lansoprazole, amoxicillin and levofloxacin
|
lansoprazole, amoxicilline et lévofloxacine
|
WHO |
Active |
2023-01-27 11:47:53 |
| A02BD11 |
pantoprazole, amoxicillin, clarithromycin and metronidazole
|
pantoprazole, amoxicilline, clarithromycine et métronidazole
|
WHO |
Active |
2023-01-27 11:48:36 |
| A02BD12 |
rabeprazole, amoxicillin and clarithromycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A02BD13 |
rabeprazole, amoxicillin and metronidazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A02BD14 |
vonoprazan, amoxicillin and clarithromycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A02BD15 |
vonoprazan, amoxicillin and metronidazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A02BX |
Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
|
Autres médicaments en cas d'ulcère peptique et de reflux gastro-œsophageal (en anglais : GORD)
|
WHO |
Active |
2021-06-09 15:34:07 |
| A02BX01 |
carbenoxolone
|
carbénoxolone
|
WHO |
Active |
2023-01-27 11:49:18 |
| A02BX02 |
sucralfate
|
Sucralfate
|
WHO |
Active |
2021-06-09 15:34:07 |
| A02BX03 |
pirenzepine
|
pirenzépine
|
WHO |
Active |
2023-01-27 11:50:01 |
| A02BX04 |
methiosulfonium chloride
|
chlorure de méthiosulfonium
|
WHO |
Active |
2023-01-27 11:50:43 |
| A02BX05 |
bismuth subcitrate
|
sous-citrate de bismuth
|
WHO |
Active |
2023-01-27 11:51:25 |
| A02BX06 |
proglumide
|
proglumide (en)
|
WHO |
Active |
2023-01-27 11:52:07 |
| A02BX07 |
gefarnate
|
gefarnate
|
WHO |
Active |
2023-01-27 11:52:49 |
| A02BX08 |
sulglicotide
|
sulglicotide
|
WHO |
Active |
2023-01-27 11:53:32 |
| A02BX09 |
acetoxolone
|
acétoxolone
|
WHO |
Active |
2023-01-27 11:54:15 |
| A02BX10 |
zolimidine
|
zolimidine
|
WHO |
Active |
2023-01-27 11:54:58 |
| A02BX11 |
troxipide
|
troxipide
|
WHO |
Active |
2023-01-27 11:55:41 |
| A02BX12 |
bismuth subnitrate
|
sous-nitrate de bismuth
|
WHO |
Active |
2023-01-27 11:56:24 |
| A02BX13 |
alginic acid
|
acide alginique
|
WHO |
Active |
2023-01-27 11:57:07 |
| A02BX14 |
rebamipide
|
rébamipide
|
WHO |
Active |
2023-01-27 11:57:48 |
| A02BX51 |
carbenoxolone, combinations excl. psycholeptics
|
carbénoxolone, associations sans psycholeptiques
|
WHO |
Active |
2023-01-27 11:58:31 |
| A02BX77 |
gefarnate, combinations with psycholeptics
|
gefarnate, associations impliquant des psycholeptiques
|
WHO |
Active |
2023-01-31 13:10:43 |
| A03AA |
Synthetic anticholinergics, esters with tertiary amino group
|
Anticholinergiques synthétiques, esters d'amines tertiaires
|
WHO |
Active |
2021-06-09 15:34:07 |
| A03AA01 |
oxyphencyclimine
|
oxyphencyclimine
|
WHO |
Active |
2023-01-31 13:11:28 |
| A03AA03 |
camylofin
|
camylofine
|
WHO |
Active |
2023-01-31 13:12:12 |
| A03AA04 |
mebeverine
|
mébévérine
|
WHO |
Active |
2023-01-31 13:12:56 |
| A03AA05 |
trimebutine
|
trimébutine
|
WHO |
Active |
2023-01-31 13:13:40 |
| A03AA06 |
rociverine
|
rocivérine
|
WHO |
Active |
2023-01-31 13:14:22 |
| A03AA07 |
dicycloverine
|
dicyclovérine
|
WHO |
Active |
2023-01-31 13:15:06 |
| A03AA08 |
dihexyverine
|
dihexyvérine
|
WHO |
Active |
2023-01-31 13:15:48 |
| A03AA09 |
difemerine
|
difemerine
|
WHO |
Active |
2023-01-31 13:16:32 |
| A03AA30 |
piperidolate
|
pipéridolate
|
WHO |
Active |
2023-01-31 13:17:15 |
| A03AB |
Synthetic anticholinergics, quaternary ammonium compounds
|
Anticholinergiques synthétiques, ammoniums quaternaires
|
WHO |
Active |
2021-06-09 15:34:07 |
| A03AB01 |
benzilone
|
benzilone
|
WHO |
Active |
2023-01-31 13:18:00 |
| A03AB02 |
glycopyrronium bromide
|
Bromure de Glycopyrronium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A03AB03 |
oxyphenonium
|
oxyphenonium
|
WHO |
Active |
2023-01-31 13:18:42 |
| A03AB04 |
penthienate
|
penthiénate
|
WHO |
Active |
2023-01-31 13:19:24 |
| A03AB05 |
propantheline
|
propanthéline
|
WHO |
Active |
2023-01-31 13:20:05 |
| A03AB06 |
otilonium bromide
|
bromure d'otilonium
|
WHO |
Active |
2023-01-31 13:20:48 |
| A03AB07 |
methantheline
|
méthanthéline
|
WHO |
Active |
2023-01-31 13:21:30 |
| A03AB08 |
tridihexethyl
|
tridihexéthyl
|
WHO |
Active |
2023-01-31 13:22:12 |
| A03AB09 |
isopropamide
|
isopropamide
|
WHO |
Active |
2023-01-31 13:22:54 |
| A03AB10 |
hexocyclium
|
hexocyclium
|
WHO |
Active |
2023-01-31 13:23:38 |
| A03AB11 |
poldine
|
poldine
|
WHO |
Active |
2023-01-31 13:24:21 |
| A03AB12 |
mepenzolate
|
mépenzolate
|
WHO |
Active |
2023-01-31 13:25:03 |
| A03AB13 |
bevonium
|
bévonium
|
WHO |
Active |
2023-01-31 13:25:47 |
| A03AB14 |
pipenzolate
|
pipenzolate
|
WHO |
Active |
2023-01-31 13:26:31 |
| A03AB15 |
diphemanil
|
diphémanil
|
WHO |
Active |
2023-01-31 13:27:15 |
| A03AB17 |
tiemonium iodide
|
iodure de tiémonium
|
WHO |
Active |
2023-01-31 13:27:59 |
| A03AB18 |
prifinium bromide
|
bromure de prifinium
|
WHO |
Active |
2023-01-31 17:15:11 |
| A03AB19 |
timepidium bromide
|
bromure de timépidium
|
WHO |
Active |
2023-01-31 17:15:53 |
| A03AB21 |
fenpiverinium
|
fenpivérinium
|
WHO |
Active |
2023-01-31 17:16:38 |
| A03AB53 |
oxyphenonium, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A03AC |
Synthetic antispasmodics, amides with tertiary amines
|
Antispasmodiques de synthèse, amides d'amines tertiaires
|
WHO |
Active |
2021-06-09 15:34:07 |
| A03AC04 |
nicofetamide
|
nicofétamide
|
WHO |
Active |
2023-01-31 17:17:20 |
| A03AC05 |
tiropramide
|
tiropramide
|
WHO |
Active |
2023-01-31 17:18:03 |
| A03AD |
Papaverine and derivatives
|
Papavérine et dérivés
|
WHO |
Active |
2021-06-09 15:34:07 |
| A03AD01 |
papaverine
|
papavérine
|
WHO |
Active |
2023-01-31 17:18:49 |
| A03AD02 |
drotaverine
|
drotavérine
|
WHO |
Active |
2023-01-31 17:19:32 |
| A03AD30 |
moxaverine
|
moxavérine
|
WHO |
Active |
2023-01-31 17:20:18 |
| A03AE |
Serotonin receptor antagonists
|
Substances agissant sur les récepteurs de la sérotonine
|
WHO |
Active |
2021-06-09 15:34:07 |
| A03AE01 |
alosetron
|
alosétron
|
WHO |
Active |
2023-01-31 17:21:02 |
| A03AE03 |
cilansetron
|
cilansétron
|
WHO |
Active |
2023-01-31 17:21:45 |
| A03AX |
Other drugs for functional gastrointestinal disorders
|
Autres médicaments en cas de troubles fonctionnels du côlon
|
WHO |
Active |
2021-06-09 15:34:07 |
| A03AX01 |
fenpiprane
|
fenpiprane
|
WHO |
Active |
2023-01-31 17:22:28 |
| A03AX02 |
diisopromine
|
diisopromine
|
WHO |
Active |
2023-01-31 17:23:11 |
| A03AX03 |
chlorbenzoxamine
|
chlorbenzoxamine
|
WHO |
Active |
2023-01-31 17:23:53 |
| A03AX04 |
pinaverium
|
pinaverium
|
WHO |
Active |
2023-01-31 17:24:37 |
| A03AX05 |
fenoverine
|
fenoverine
|
WHO |
Active |
2023-01-31 17:25:19 |
| A03AX06 |
idanpramine
|
idanpramine
|
WHO |
Active |
2023-01-31 17:26:00 |
| A03AX07 |
proxazole
|
proxazole
|
WHO |
Active |
2023-01-31 17:26:44 |
| A03AX08 |
alverine
|
alvérine
|
WHO |
Active |
2023-01-31 17:27:27 |
| A03AX09 |
trepibutone
|
trepibutone
|
WHO |
Active |
2023-01-31 17:28:10 |
| A03AX10 |
isometheptene
|
isometheptene
|
WHO |
Active |
2023-01-31 17:28:53 |
| A03AX11 |
caroverine
|
caroverine
|
WHO |
Active |
2023-01-31 17:29:38 |
| A03AX12 |
phloroglucinol
|
phloroglucinol
|
WHO |
Active |
2023-01-31 17:30:21 |
| A03AX13 |
silicones
|
silicones
|
WHO |
Active |
2023-01-31 17:31:05 |
| A03AX14 |
valethamate
|
valéthamate
|
WHO |
Active |
2023-01-31 17:31:50 |
| A03AX30 |
trimethyldiphenylpropylamine
|
triméthyldiphenylpropylamine
|
WHO |
Active |
2023-01-31 17:32:35 |
| A03AX58 |
alverine, combinations
|
alvérine, assocations
|
WHO |
Active |
2023-02-01 09:47:23 |
| A03BA |
Belladonna alkaloids, tertiary amines
|
Alcaloïdes de la belladone, amines tertiaires
|
WHO |
Active |
2021-06-09 15:34:07 |
| A03BA01 |
atropine
|
atropine
|
WHO |
Active |
2023-02-01 09:48:08 |
| A03BA03 |
hyoscyamine
|
hyoscyamine
|
WHO |
Active |
2023-02-01 09:48:50 |
| A03BA04 |
belladonna total alkaloids
|
alcaloïdes totaux de la belladone
|
WHO |
Active |
2023-02-01 09:49:33 |
| A03BB |
Belladonna alkaloids, semisynthetic, quaternary ammonium compounds
|
Alcaloïdes de la belladone, semisynthétiques, ammoniums quaternaires
|
WHO |
Active |
2021-06-09 15:34:07 |
| A03BB01 |
butylscopolamine
|
butylscopolamine
|
WHO |
Active |
2023-02-01 09:50:16 |
| A03BB02 |
methylatropine
|
méthylatropine
|
WHO |
Active |
2023-02-01 09:50:58 |
| A03BB03 |
methylscopolamine
|
méthylscopolamine
|
WHO |
Active |
2023-02-01 09:51:42 |
| A03BB04 |
fentonium
|
fentonium
|
WHO |
Active |
2023-02-01 09:52:26 |
| A03BB05 |
cimetropium bromide
|
bromure de cimétropium
|
WHO |
Active |
2023-02-01 09:53:08 |
| A03BB06 |
homatropine methylbromide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A03CA |
Synthetic anticholinergic agents in combination with psycholeptics
|
Anticholinergiques de synthèse associés à des psycholeptiques
|
WHO |
Active |
2021-06-09 15:34:07 |
| A03CA01 |
isopropamide and psycholeptics
|
isopropamide et psycholeptiques
|
WHO |
Active |
2023-02-01 09:53:51 |
| A03CA02 |
clidinium and psycholeptics
|
clidinium et psycholeptiques
|
WHO |
Active |
2023-02-01 09:54:33 |
| A03CA03 |
oxyphencyclimine and psycholeptics
|
oxyphencyclimine et psycholeptiques
|
WHO |
Active |
2023-02-01 09:55:16 |
| A03CA04 |
otilonium bromide and psycholeptics
|
bromure d'otilonium et psycholeptiques
|
WHO |
Active |
2023-02-01 09:56:00 |
| A03CA05 |
glycopyrronium bromide and psycholeptics
|
glycopyrronium et psycholeptiques
|
WHO |
Active |
2023-02-01 09:56:43 |
| A03CA06 |
bevonium and psycholeptics
|
bevonium et psycholeptiques
|
WHO |
Active |
2023-02-01 09:57:24 |
| A03CA07 |
ambutonium and psycholeptics
|
ambutonium et psycholeptiques
|
WHO |
Active |
2023-02-01 09:58:06 |
| A03CA09 |
pipenzolate and psycholeptics
|
pipenzolate et psycholeptiques
|
WHO |
Active |
2023-02-01 09:58:49 |
| A03CA30 |
emepronium and psycholeptics
|
emepronium et psycholeptiques
|
WHO |
Active |
2023-02-01 09:59:33 |
| A03CA34 |
propantheline and psycholeptics
|
propanthéline et psycholeptiques
|
WHO |
Active |
2023-02-01 10:00:16 |
| A03CB |
Belladonna and derivatives in combination with psycholeptics
|
Belladone et dérivés associés à des psycholeptiques
|
WHO |
Active |
2021-06-09 15:34:07 |
| A03CB01 |
methylscopolamine and psycholeptics
|
méthylscopolamine et psycholeptiques
|
WHO |
Active |
2023-02-01 10:00:58 |
| A03CB02 |
belladonna total alkaloids and psycholeptics
|
alcaloïdes totaux de la belladone et psycholeptiques
|
WHO |
Active |
2023-02-01 10:01:41 |
| A03CB03 |
atropine and psycholeptics
|
atropine et psycholeptiques
|
WHO |
Active |
2023-02-01 10:02:23 |
| A03CB04 |
homatropine methylbromide and psycholeptics
|
méthylhomatropine et psycholeptiques
|
WHO |
Active |
2023-02-01 10:03:05 |
| A03CB31 |
hyoscyamine and psycholeptics
|
hyoscyamine et psycholeptiques
|
WHO |
Active |
2023-02-01 10:03:48 |
| A03DA |
Synthetic anticholinergic agents in combination with analgesics
|
Anticholinergiques de synthèse associés à des analgésiques
|
WHO |
Active |
2021-06-09 15:34:07 |
| A03DA02 |
pitofenone and analgesics
|
pitofenone et analgésiques
|
WHO |
Active |
2023-02-01 10:04:30 |
| A03DA04 |
ciclonium and analgesics
|
ciclonium et analgésiques
|
WHO |
Active |
2023-02-03 11:06:38 |
| A03DA05 |
camylofin and analgesics
|
camylofin et analgésiques
|
WHO |
Active |
2023-02-03 11:07:24 |
| A03DA06 |
trospium and analgesics
|
trospium et analgésiques
|
WHO |
Active |
2023-02-03 11:08:08 |
| A03DA07 |
tiemonium iodide and analgesics
|
iodure de tiémonium et analgésiques
|
WHO |
Active |
2023-02-03 11:08:50 |
| A03DB |
Belladonna and derivatives in combination with analgesics
|
Belladone et dérivés associés à des analgésiques
|
WHO |
Active |
2021-06-09 15:34:07 |
| A03DB04 |
butylscopolamine and analgesics
|
butylscopolamine et analgésiques
|
WHO |
Active |
2023-02-03 11:09:34 |
| A03FA |
Propulsives
|
Propulsifs
|
WHO |
Active |
2021-06-09 15:34:07 |
| A03FA01 |
metoclopramide
|
métoclopramide
|
WHO |
Active |
2023-02-03 11:10:16 |
| A03FA02 |
cisapride
|
cisapride
|
WHO |
Active |
2023-02-03 11:11:00 |
| A03FA03 |
domperidone
|
Dompéridone
|
WHO |
Active |
2021-06-09 15:34:07 |
| A03FA04 |
bromopride
|
bromopride
|
WHO |
Active |
2023-02-03 11:11:44 |
| A03FA05 |
alizapride
|
alizapride
|
WHO |
Active |
2023-02-03 11:12:26 |
| A03FA06 |
clebopride
|
clébopride
|
WHO |
Active |
2023-02-03 11:13:10 |
| A03FA07 |
itopride
|
itropride
|
WHO |
Active |
2023-02-03 11:13:53 |
| A03FA08 |
cinitapride
|
cinitapride
|
WHO |
Active |
2023-02-03 11:14:35 |
| A03FA09 |
mosapride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A04AA |
Serotonin (5HT3) antagonists
|
antagonistes de la sérotonine (Antagonistes 5HT3)
|
WHO |
Active |
2021-06-09 15:34:07 |
| A04AA01 |
ondansetron
|
Ondansétron
|
WHO |
Active |
2021-06-09 15:34:07 |
| A04AA02 |
granisetron
|
Granisétron
|
WHO |
Active |
2021-06-09 15:34:07 |
| A04AA03 |
tropisetron
|
tropisetron
|
WHO |
Active |
2023-02-03 11:15:23 |
| A04AA04 |
dolasetron
|
dolasétron
|
WHO |
Active |
2023-02-03 11:16:05 |
| A04AA05 |
palonosetron
|
Palonosétron
|
WHO |
Active |
2021-06-09 15:34:07 |
| A04AA55 |
palonosetron, combinations
|
palonosétron, associations
|
WHO |
Active |
2023-02-03 11:16:48 |
| A04AD |
Other antiemetics
|
Autres antiémétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
| A04AD01 |
scopolamine
|
scopolamine
|
WHO |
Active |
2023-02-03 11:17:32 |
| A04AD02 |
cerium oxalate
|
oxalate de cérium
|
WHO |
Active |
2023-02-03 11:18:15 |
| A04AD04 |
chlorobutanol
|
Chlorobutanol
|
WHO |
Active |
2021-06-09 15:34:07 |
| A04AD05 |
metopimazine
|
métopimazine
|
WHO |
Active |
2023-02-03 11:19:00 |
| A04AD10 |
dronabinol
|
mronabinol
|
WHO |
Active |
2023-02-03 11:19:43 |
| A04AD11 |
nabilone
|
Nabilone
|
WHO |
Active |
2021-06-09 15:34:07 |
| A04AD12 |
aprepitant
|
Aprépitant
|
WHO |
Active |
2021-06-09 15:34:07 |
| A04AD13 |
casopitant
|
casopitant
|
WHO |
Active |
2023-02-03 11:20:27 |
| A04AD14 |
rolapitant
|
rolapitant
|
WHO |
Active |
2023-02-03 11:21:13 |
| A04AD51 |
scopolamine, combinations
|
scopolamine, associations
|
WHO |
Active |
2023-02-03 11:21:57 |
| A04AD54 |
chlorobutanol, combinations
|
chlorobutanol, associations
|
WHO |
Active |
2023-02-03 11:22:40 |
| A05AA |
Bile acids and derivatives
|
Acides biliaires et dérivés
|
WHO |
Active |
2021-06-09 15:34:07 |
| A05AA01 |
chenodeoxycholic acid
|
acide chénodésoxycholique
|
WHO |
Active |
2023-02-03 11:23:22 |
| A05AA02 |
ursodeoxycholic acid
|
acide ursodésoxycholique
|
WHO |
Active |
2023-02-03 11:24:05 |
| A05AA03 |
cholic acid
|
acide cholique
|
WHO |
Active |
2023-02-03 12:36:51 |
| A05AA04 |
obeticholic acid
|
Acide obéticholique
|
WHO |
Active |
2021-06-09 15:34:07 |
| A05AB |
Preparations for biliary tract therapy
|
Préparations pour le traitement du conduit biliaire
|
WHO |
Active |
2021-06-09 15:34:07 |
| A05AB01 |
nicotinyl methylamide
|
nicotinyl méthylamide
|
WHO |
Active |
2023-02-03 12:37:34 |
| A05AX |
Other drugs for bile therapy
|
Autres médicaments pour le traitement de la bile
|
WHO |
Active |
2021-06-09 15:34:07 |
| A05AX01 |
piprozolin
|
piprozoline
|
WHO |
Active |
2023-02-03 14:06:00 |
| A05AX02 |
hymecromone
|
hymécromone
|
WHO |
Active |
2023-02-03 14:06:41 |
| A05AX03 |
cyclobutyrol
|
cyclobutyrol
|
WHO |
Active |
2023-02-03 14:07:24 |
| A05BA |
Liver therapy
|
Traitement du foie
|
WHO |
Active |
2021-06-09 15:34:07 |
| A05BA01 |
arginine glutamate
|
arginine glutamate
|
WHO |
Active |
2023-02-03 14:08:07 |
| A05BA03 |
silymarin
|
silymarine
|
WHO |
Active |
2023-02-03 14:08:49 |
| A05BA04 |
citiolone
|
citiolone
|
WHO |
Active |
2023-02-03 14:09:32 |
| A05BA05 |
epomediol
|
épomédiol
|
WHO |
Active |
2023-02-03 14:10:15 |
| A05BA06 |
ornithine oxoglurate
|
ornithine oxoglurate
|
WHO |
Active |
2023-02-03 14:10:58 |
| A05BA07 |
tidiacic arginine
|
arginine tidiacique
|
WHO |
Active |
2023-02-03 14:11:42 |
| A05BA08 |
glycyrrhizic acid
|
acide glycyrrhizique (glycyrrhizine)
|
WHO |
Active |
2023-02-03 14:12:25 |
| A06AA |
Softeners, emollients
|
émollients
|
WHO |
Active |
2021-06-09 15:34:07 |
| A06AA01 |
liquid paraffin
|
paraffine liquide
|
WHO |
Active |
2023-02-03 14:13:08 |
| A06AA02 |
docusate sodium
|
Docusate sodique
|
WHO |
Active |
2021-06-09 15:34:07 |
| A06AA51 |
liquid paraffin, combinations
|
associations à base de paraffine liquide
|
WHO |
Active |
2023-02-03 14:13:50 |
| A06AB |
Contact laxatives
|
laxatifs de contact
|
WHO |
Active |
2021-06-09 15:34:07 |
| A06AB01 |
oxyphenisatine
|
oxyphénisatine
|
WHO |
Active |
2023-02-03 14:14:33 |
| A06AB02 |
bisacodyl
|
Bisacodyl
|
WHO |
Active |
2021-06-09 15:34:07 |
| A06AB03 |
dantron
|
dantrone
|
WHO |
Active |
2023-02-03 14:15:15 |
| A06AB04 |
phenolphthalein
|
phénolphtaléine
|
WHO |
Active |
2023-02-03 14:15:59 |
| A06AB05 |
castor oil
|
huile de ricin
|
WHO |
Active |
2023-02-03 14:16:41 |
| A06AB06 |
senna glycosides
|
glycosides du Senna
|
WHO |
Active |
2023-02-03 14:17:26 |
| A06AB07 |
cascara
|
cascara
|
WHO |
Active |
2023-02-03 14:18:11 |
| A06AB08 |
sodium picosulfate
|
Picosulfate sodique
|
WHO |
Active |
2021-06-09 15:34:07 |
| A06AB09 |
bisoxatin
|
bisoxatine
|
WHO |
Active |
2023-02-03 14:18:55 |
| A06AB20 |
contact laxatives in combination
|
laxatifs de contact en association
|
WHO |
Active |
2023-02-03 14:19:40 |
| A06AB30 |
contact laxatives in combination with belladonna alkaloids
|
laxatifs de contact en association avec de la belladone alcaloïde
|
WHO |
Active |
2023-02-03 14:20:23 |
| A06AB52 |
bisacodyl, combinations
|
bisacodyl, associations
|
WHO |
Active |
2023-02-03 14:21:04 |
| A06AB53 |
dantron, combinations
|
dantrone, associations
|
WHO |
Active |
2023-02-03 14:21:49 |
| A06AB56 |
senna glycosides, combinations
|
senna glycosides, associations
|
WHO |
Active |
2023-02-03 14:22:33 |
| A06AB57 |
cascara, combinations
|
cascara, associations
|
WHO |
Active |
2023-02-03 14:23:15 |
| A06AB58 |
sodium picosulfate, combinations
|
picosulfate de sodium, associations
|
WHO |
Active |
2023-02-03 14:23:58 |
| A06AC |
Bulk-forming laxatives
|
Laxatifs de lest
|
WHO |
Active |
2021-06-09 15:34:07 |
| A06AC01 |
ispaghula (psylla seeds)
|
ispaghula (semences de Psylla)
|
WHO |
Active |
2023-02-03 14:24:41 |
| A06AC02 |
ethulose
|
éthulose
|
WHO |
Active |
2023-02-03 14:25:24 |
| A06AC03 |
sterculia
|
sterculia
|
WHO |
Active |
2023-02-03 14:26:06 |
| A06AC05 |
linseed
|
semence de lin
|
WHO |
Active |
2023-02-03 14:26:49 |
| A06AC06 |
methylcellulose
|
Méthylcellulose
|
WHO |
Active |
2021-06-09 15:34:07 |
| A06AC07 |
triticum (wheat fibre)
|
triticum (fibre)
|
WHO |
Active |
2023-02-03 14:27:32 |
| A06AC08 |
polycarbophil calcium
|
polycarbophil calcium
|
WHO |
Active |
2023-02-03 14:28:15 |
| A06AC51 |
ispaghula, combinations
|
ispaghul, associations
|
WHO |
Active |
2023-02-03 14:28:58 |
| A06AC53 |
sterculia, combinations
|
sterculia, associations
|
WHO |
Active |
2023-02-03 14:29:40 |
| A06AC55 |
linseed, combinations
|
semence de lin, associations
|
WHO |
Active |
2023-02-03 14:30:22 |
| A06AD |
Osmotically acting laxatives
|
laxatifs osmotiques
|
WHO |
Active |
2021-06-09 15:34:07 |
| A06AD01 |
magnesium carbonate
|
Carbonate de magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A06AD02 |
magnesium oxide
|
Oxyde de magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A06AD03 |
magnesium peroxide
|
peroxyde de magnésium
|
WHO |
Active |
2023-02-03 14:31:06 |
| A06AD04 |
magnesium sulfate
|
Sulfate de magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A06AD10 |
mineral salts in combination
|
sels minéraux en association
|
WHO |
Active |
2023-02-03 14:31:49 |
| A06AD11 |
lactulose
|
Lactulose
|
WHO |
Active |
2021-06-09 15:34:07 |
| A06AD12 |
lactitol
|
lactitol
|
WHO |
Active |
2023-02-03 14:32:31 |
| A06AD13 |
sodium sulfate
|
Sulfate de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A06AD15 |
macrogol
|
Macrogol
|
WHO |
Active |
2021-06-09 15:34:07 |
| A06AD16 |
mannitol
|
Mannitol
|
WHO |
Active |
2021-06-09 15:34:07 |
| A06AD17 |
sodium phosphate
|
phosphate trisodique
|
WHO |
Active |
2023-02-03 14:33:13 |
| A06AD18 |
sorbitol
|
Sorbitol
|
WHO |
Active |
2021-06-09 15:34:07 |
| A06AD19 |
magnesium citrate
|
citrate de magnésium
|
WHO |
Active |
2023-02-03 14:33:56 |
| A06AD21 |
sodium tartrate
|
tartrate de sodium
|
WHO |
Active |
2023-02-03 14:34:39 |
| A06AD61 |
lactulose, combinations
|
lactulose, associations
|
WHO |
Active |
2023-02-03 14:35:21 |
| A06AD65 |
macrogol, combinations
|
macrogol, associations
|
WHO |
Active |
2023-02-03 14:36:03 |
| A06AG |
Enemas
|
Lavements
|
WHO |
Active |
2021-06-09 15:34:07 |
| A06AG01 |
sodium phosphate
|
phosphate trisodique
|
WHO |
Active |
2023-02-03 14:36:46 |
| A06AG02 |
bisacodyl
|
Bisacodyl
|
WHO |
Active |
2021-06-09 15:34:07 |
| A06AG03 |
dantron, incl. combinations
|
dantrone, y compris les associations
|
WHO |
Active |
2023-02-03 14:37:29 |
| A06AG04 |
glycerol
|
glycérol
|
WHO |
Active |
2023-02-03 14:38:11 |
| A06AG07 |
sorbitol
|
Sorbitol
|
WHO |
Active |
2021-06-09 15:34:07 |
| A06AG10 |
docusate sodium, incl. combinations
|
docusate de sodium, y compris les associations
|
WHO |
Active |
2023-02-03 14:38:52 |
| A06AG11 |
sodium lauryl sulfoacetate, incl. combinations
|
sodium lauryl sulfoacetate, y compris les associations
|
WHO |
Active |
2023-02-03 14:39:34 |
| A06AG20 |
combinations
|
associations
|
WHO |
Active |
2023-02-03 14:40:17 |
| A06AH |
Peripheral opioid receptor antagonists
|
Antagonistes de récepteurs opioïdes périphériques
|
WHO |
Active |
2021-06-09 15:34:07 |
| A06AH01 |
methylnaltrexone bromide
|
Bromure de méthylnaltrexone
|
WHO |
Active |
2021-06-09 15:34:07 |
| A06AH02 |
alvimopan
|
alvimopan
|
WHO |
Active |
2023-02-03 14:41:00 |
| A06AH03 |
naloxegol
|
Naloxégol
|
WHO |
Active |
2021-06-09 15:34:07 |
| A06AH04 |
naloxone
|
Naloxone
|
WHO |
Active |
2021-06-09 15:34:07 |
| A06AX |
Other drugs for constipation
|
Autres laxatifs
|
WHO |
Active |
2021-06-09 15:34:07 |
| A06AX01 |
glycerol
|
glycérol
|
WHO |
Active |
2023-02-03 14:41:45 |
| A06AX02 |
carbon dioxide producing drugs
|
médicaments producteurs de dioxyde de carbone
|
WHO |
Active |
2023-02-03 14:42:27 |
| A06AX03 |
lubiprostone
|
lubiprostone
|
WHO |
Active |
2023-02-03 14:43:10 |
| A06AX04 |
linaclotide
|
Linaclotide
|
WHO |
Active |
2021-06-09 15:34:07 |
| A06AX05 |
prucalopride
|
Prucalopride
|
WHO |
Active |
2021-06-09 15:34:07 |
| A06AX06 |
tegaserod
|
tégasérod
|
WHO |
Active |
2023-02-03 14:43:53 |
| A06AX07 |
plecanatide
|
Plécanatide
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07AA |
Antibiotics
|
Antibiotiques
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07AA01 |
neomycin
|
Néomycine
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07AA02 |
nystatin
|
Nystatine
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07AA03 |
natamycin
|
natamycine
|
WHO |
Active |
2023-02-03 14:44:35 |
| A07AA04 |
streptomycin
|
Streptomycine
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07AA05 |
polymyxin B
|
Polymyxine B
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07AA06 |
paromomycin
|
Paromomycine
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07AA07 |
amphotericin B
|
Amphotéricine b
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07AA08 |
kanamycin
|
kanamycine
|
WHO |
Active |
2023-02-03 14:45:17 |
| A07AA09 |
vancomycin
|
Vancomycine
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07AA10 |
colistin
|
Colistine
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07AA11 |
rifaximin
|
RIFAXIMINE
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07AA12 |
fidaxomicin
|
Fidaxomicine
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07AA13 |
rifamycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07AA51 |
neomycin, combinations
|
néomycine, associations
|
WHO |
Active |
2023-02-03 14:46:00 |
| A07AA54 |
streptomycin, combinations
|
streptomycine, associations
|
WHO |
Active |
2023-02-03 14:46:41 |
| A07AB |
Sulfonamides
|
Sulfamidés
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07AB02 |
phthalylsulfathiazole
|
phtalylsulfathiazole
|
WHO |
Active |
2023-02-03 14:47:23 |
| A07AB03 |
sulfaguanidine
|
Sulfaguanidine
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07AB04 |
succinylsulfathiazole
|
Succinylsulfathiazol
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07AC |
Imidazole derivatives
|
Dérivés de l'imidazole
|
WHO |
Active |
2021-10-25 19:07:10 |
| A07AC01 |
miconazole
|
Miconazole
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07AX |
Other intestinal antiinfectives
|
Autres antiseptiques intestinaux
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07AX01 |
broxyquinoline
|
broxyquinoline
|
WHO |
Active |
2023-02-03 14:48:06 |
| A07AX02 |
acetarsol
|
acétarsol
|
WHO |
Active |
2023-02-03 14:48:50 |
| A07AX03 |
nifuroxazide
|
nifuroxazide
|
WHO |
Active |
2023-02-03 14:49:33 |
| A07AX04 |
nifurzide
|
nifurzide
|
WHO |
Active |
2023-02-03 14:50:16 |
| A07BA |
Charcoal preparations
|
Préparations à base de charbon activé
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07BA01 |
medicinal charcoal
|
charbon médicinal
|
WHO |
Active |
2023-02-03 14:51:00 |
| A07BA51 |
medicinal charcoal, combinations
|
charbon médicinal, associations
|
WHO |
Active |
2023-02-03 14:51:42 |
| A07BC |
Other intestinal adsorbents
|
Autres absorbants intestinaux
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07BC01 |
pectin
|
Pectine
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07BC02 |
kaolin
|
Kaolin
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07BC03 |
crospovidone
|
crospovidone
|
WHO |
Active |
2023-02-03 14:52:24 |
| A07BC04 |
attapulgite
|
attapulgite
|
WHO |
Active |
2023-02-03 14:53:07 |
| A07BC05 |
diosmectite
|
diosmectite
|
WHO |
Active |
2023-02-03 14:53:50 |
| A07BC30 |
combinations
|
associations
|
WHO |
Active |
2023-02-03 14:54:34 |
| A07BC54 |
attapulgite, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07DA |
Antipropulsives
|
Antipropulsivants
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07DA01 |
diphenoxylate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07DA02 |
opium
|
Opium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07DA03 |
loperamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07DA04 |
difenoxin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07DA05 |
loperamide oxide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07DA06 |
eluxadoline
|
ELUXADOLINE
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07DA52 |
morphine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07DA53 |
loperamide, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07EA |
Corticosteroids acting locally
|
Corticostéroïdes locaux
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07EA01 |
prednisolone
|
Prednisolone
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07EA02 |
hydrocortisone
|
Hydrocortisone
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07EA03 |
prednisone
|
Prednisone
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07EA04 |
betamethasone
|
Bétaméthasone
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07EA05 |
tixocortol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07EA06 |
budesonide
|
Budésonide
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07EA07 |
beclometasone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07EB |
Antiallergic agents, excl. corticosteroids
|
Antiallergiques, à l'exclusion des corticostéroïdes
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07EB01 |
cromoglicic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07EC |
Aminosalicylic acid and similar agents
|
Acide aminosalicylique et agents apparenté
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07EC01 |
sulfasalazine
|
Sulfasalazine
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07EC02 |
mesalazine
|
Mésalazine
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07EC03 |
olsalazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07EC04 |
balsalazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07FA |
Antidiarrheal microorganisms
|
Micro-organismes antidiarrhéiques
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07FA01 |
lactic acid producing organisms
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07FA02 |
saccharomyces boulardii
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07FA51 |
lactic acid producing organisms, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07XA |
Other antidiarrheals
|
Autres antidiarrhéiques
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07XA01 |
albumin tannate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07XA02 |
ceratonia
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07XA04 |
racecadotril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07XA06 |
crofelemer
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A07XA51 |
albumin tannate, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A08AA |
Centrally acting antiobesity products
|
Produits antiobésité d'action centrale
|
WHO |
Active |
2021-06-09 15:34:07 |
| A08AA01 |
phentermine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A08AA02 |
fenfluramine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A08AA03 |
amfepramone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A08AA04 |
dexfenfluramine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A08AA05 |
mazindol
|
Mazindol
|
WHO |
Active |
2021-06-09 15:34:07 |
| A08AA06 |
etilamfetamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A08AA07 |
cathine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A08AA08 |
clobenzorex
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A08AA09 |
mefenorex
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A08AA10 |
sibutramine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A08AA11 |
lorcaserin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A08AA56 |
ephedrine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A08AA62 |
bupropion and naltrexone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A08AB |
Peripherally acting antiobesity products
|
Produits antiobésité d'action périphérique
|
WHO |
Active |
2021-06-09 15:34:07 |
| A08AB01 |
orlistat
|
Orlistat
|
WHO |
Active |
2021-06-09 15:34:07 |
| A08AX |
Other antiobesity drugs
|
Autres médicaments anti obésité
|
WHO |
Active |
2021-06-09 15:34:07 |
| A08AX01 |
rimonabant
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A09AA |
Enzyme preparations
|
Enzyme - préparations
|
WHO |
Active |
2021-06-09 15:34:07 |
| A09AA01 |
diastase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A09AA02 |
multienzymes (lipase, protease etc.)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A09AA03 |
pepsin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A09AA04 |
tilactase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A09AB |
Acid preparations
|
Acide - préparations
|
WHO |
Active |
2021-06-09 15:34:07 |
| A09AB01 |
glutamic acid hydrochloride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A09AB02 |
betaine hydrochloride
|
Chlorhydrate de bétaïne
|
WHO |
Active |
2021-06-09 15:34:07 |
| A09AB03 |
hydrochloric acid
|
Acide chlorhydrique
|
WHO |
Active |
2021-06-09 15:34:07 |
| A09AB04 |
citric acid
|
Acide citrique
|
WHO |
Active |
2021-06-09 15:34:07 |
| A09AC |
Enzyme and acid preparations, combinations
|
Enzyme et acide - préparations en combinaiso
|
WHO |
Active |
2021-10-25 19:07:13 |
| A09AC01 |
pepsin and acid preparations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A09AC02 |
multienzymes and acid preparations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10AB |
Insulins and analogues for injection, fast-acting
|
Insulines et analogues pour injection, à action rapide
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10AB01 |
insulin (human)
|
Insuline (humaine)
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10AB02 |
insulin (beef)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10AB03 |
insulin (pork)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10AB04 |
insulin lispro
|
Insuline lispro
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10AB05 |
insulin aspart
|
Insuline asparte
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10AB06 |
insulin glulisine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10AB30 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10AC |
Insulins and analogues for injection, intermediate-acting
|
Insulines et analogues pour injection, à action intermédiaire
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10AC01 |
insulin (human)
|
Insuline (humaine)
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10AC02 |
insulin (beef)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10AC03 |
insulin (pork)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10AC04 |
insulin lispro
|
Insuline lispro
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10AC30 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10AD |
Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting
|
Insulines et analogues pour injection, à action intermédiaire ou longue combinées avec insulines à action rapide
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10AD01 |
insulin (human)
|
Insuline (humaine)
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10AD02 |
insulin (beef)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10AD03 |
insulin (pork)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10AD04 |
insulin lispro
|
Insuline lispro
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10AD05 |
insulin aspart
|
Insuline asparte
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10AD06 |
insulin degludec and insulin aspart
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10AD30 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10AE |
Insulins and analogues for injection, long-acting
|
Insulines et analogues pour injection, à action lent
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10AE01 |
insulin (human)
|
Insuline (humaine)
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10AE02 |
insulin (beef)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10AE03 |
insulin (pork)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10AE04 |
insulin glargine
|
Insuline glargine
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10AE05 |
insulin detemir
|
Insuline détemir
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10AE06 |
insulin degludec
|
Insuline dégludec
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10AE30 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10AE54 |
insulin glargine and lixisenatide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10AE56 |
insulin degludec and liraglutide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10AF |
Insulins and analogues for inhalation
|
Insulines et analogues pour inhalation
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10AF01 |
insulin (human)
|
Insuline (humaine)
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BA |
Biguanides
|
Biguanides
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BA01 |
phenformin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BA02 |
metformin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BA03 |
buformin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BB |
Sulfonylureas
|
Sulfonylurées
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BB01 |
glibenclamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BB02 |
chlorpropamide
|
Chlorpropamide
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BB03 |
tolbutamide
|
Tolbutamide
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BB04 |
glibornuride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BB05 |
tolazamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BB06 |
carbutamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BB07 |
glipizide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BB08 |
gliquidone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BB09 |
gliclazide
|
Gliclazide
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BB10 |
metahexamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BB11 |
glisoxepide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BB12 |
glimepiride
|
Glimépiride
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BB31 |
acetohexamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BC |
Sulfonamides (heterocyclic)
|
Sulfonamides (hétérocycliques)
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BC01 |
glymidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BD |
Combinations of oral blood glucose lowering drugs
|
Associations de médicaments oraux réduisant la glycémie
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BD01 |
phenformin and sulfonylureas
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BD02 |
metformin and sulfonylureas
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BD03 |
metformin and rosiglitazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BD04 |
glimepiride and rosiglitazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BD05 |
metformin and pioglitazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BD06 |
glimepiride and pioglitazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BD07 |
metformin and sitagliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BD08 |
metformin and vildagliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BD09 |
pioglitazone and alogliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BD10 |
metformin and saxagliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BD11 |
metformin and linagliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BD12 |
pioglitazone and sitagliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BD13 |
metformin and alogliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BD14 |
metformin and repaglinide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BD15 |
metformin and dapagliflozin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BD16 |
metformin and canagliflozin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BD17 |
metformin and acarbose
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BD18 |
metformin and gemigliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BD19 |
linagliptin and empagliflozin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BD20 |
metformin and empagliflozin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BD21 |
saxagliptin and dapagliflozin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BD22 |
metformin and evogliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BD23 |
metformin and ertugliflozin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BD24 |
sitagliptin and ertugliflozin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BD25 |
metformin, saxagliptin and dapagliflozin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BF |
Alpha glucosidase inhibitors
|
Inhibteurs d'alpha-glycosidase
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BF01 |
acarbose
|
Acarbose
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BF02 |
miglitol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BF03 |
voglibose
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BG |
Thiazolidinediones
|
Thiazolidinédiones
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BG01 |
troglitazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BG02 |
rosiglitazone
|
Rosiglitazone
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BG03 |
pioglitazone
|
Pioglitazone
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BH |
Dipeptidyl peptidase 4 (DPP-4) inhibitors
|
Inhibiteurs de la dipeptidyl peptidase-4 (DPP-4
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BH01 |
sitagliptin
|
Sitagliptine
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BH02 |
vildagliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BH03 |
saxagliptin
|
Saxagliptine
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BH04 |
alogliptin
|
Alogliptine
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BH05 |
linagliptin
|
Linagliptine
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BH06 |
gemigliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BH07 |
evogliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BH51 |
sitagliptin and simvastatin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BH52 |
gemigliptin and rosuvastatin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BJ |
Glucagon-like peptide-1 (GLP-1) analogues
|
Analogues du Glucagon-like peptide-1 (GLP-1)
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BJ01 |
exenatide
|
Exénatide
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BJ02 |
liraglutide
|
Liraglutide
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BJ03 |
lixisenatide
|
Lixisénatide
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BJ04 |
albiglutide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BJ05 |
dulaglutide
|
Dulaglutide
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BJ06 |
semaglutide
|
Sémaglutide
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BK |
Sodium-glucose co-transporter 2 (SGLT2) inhibitors
|
Inhibiteurs du cotransporteur sodium-glucose de type 2
|
WHO |
Active |
2023-02-24 14:56:32 |
| A10BK01 |
dapagliflozin
|
Dapagliflozine
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BK02 |
canagliflozin
|
Canagliflozine
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BK03 |
empagliflozin
|
EMPAGLIFLOZINE
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BK04 |
ertugliflozin
|
Ertugliflozine
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BK05 |
ipragliflozin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BK06 |
sotagliflozin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BX |
Other blood glucose lowering drugs, excl. insulins
|
Autres médicament réduisant la glycémie, autres que les insulines
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BX01 |
guar gum
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BX02 |
repaglinide
|
Répaglinide
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BX03 |
nateglinide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BX05 |
pramlintide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BX06 |
benfluorex
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10BX08 |
mitiglinide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10XA |
Aldose reductase inhibitors
|
Inhibiteurs d'aldose réductase
|
WHO |
Active |
2021-06-09 15:34:07 |
| A10XA01 |
tolrestat
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11AA |
Multivitamins with minerals
|
Multivitamines et minéraux
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11AA01 |
multivitamins and iron
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11AA02 |
multivitamins and calcium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11AA03 |
multivitamins and other minerals, incl. combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11AA04 |
multivitamins and trace elements
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11CA |
Vitamin A, plain
|
Vitamine A, non associée
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11CA01 |
retinol (vit A)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11CA02 |
betacarotene
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11CC |
Vitamin D and analogues
|
Vitamine D et analogues
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11CC01 |
ergocalciferol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11CC02 |
dihydrotachysterol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11CC03 |
alfacalcidol
|
Alfacalcidol
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11CC04 |
calcitriol
|
Calcitriol
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11CC05 |
colecalciferol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11CC06 |
calcifediol
|
Calcifédiol
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11CC20 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11CC55 |
colecalciferol, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11DA |
Vitamin B1, plain
|
Vitamine B1, non associée
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11DA01 |
thiamine (vit B1)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11DA02 |
sulbutiamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11DA03 |
benfotiamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11GA |
Ascorbic acid (vitamin C), plain
|
Acide ascorbique (vitamine C), non associée
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11GA01 |
ascorbic acid (vit C)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11GB |
Ascorbic acid (vitamin C), combinations
|
Acide ascorbique (vitamine C), associations
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11GB01 |
ascorbic acid (vit C) and calcium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11HA |
Other plain vitamin preparations
|
Autres préparations à base de vitamines seules
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11HA01 |
nicotinamide
|
Nicotinamide
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11HA02 |
pyridoxine (vit B6)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11HA03 |
tocopherol (vit E)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11HA04 |
riboflavin (vit B2)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11HA05 |
biotin
|
Biotine
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11HA06 |
pyridoxal phosphate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11HA07 |
inositol
|
Inositol
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11HA08 |
tocofersolan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11HA30 |
dexpanthenol
|
Dexpanthénol
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11HA31 |
calcium pantothenate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A11HA32 |
pantethine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12AA |
Calcium
|
Calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12AA01 |
calcium phosphate
|
Phosphate de calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12AA02 |
calcium glubionate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12AA03 |
calcium gluconate
|
Gluconate de calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12AA04 |
calcium carbonate
|
Carbonate de calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12AA05 |
calcium lactate
|
Lactate de calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12AA06 |
calcium lactate gluconate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12AA07 |
calcium chloride
|
Chlorure de calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12AA08 |
calcium glycerylphosphate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12AA10 |
calcium glucoheptonate
|
Glucoheptonate de calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12AA11 |
calcium pangamate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12AA13 |
calcium citrate
|
Citrate de calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12AA20 |
calcium (different salts in combination)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12AA30 |
calcium laevulate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12BA |
Potassium
|
Potassium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12BA01 |
potassium chloride
|
Chlorure de potassium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12BA02 |
potassium citrate
|
Citrate de potassium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12BA03 |
potassium hydrogentartrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12BA04 |
potassium hydrogencarbonate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12BA05 |
potassium gluconate
|
Gluconate de potassium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12BA30 |
potassium (different salts in combination)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12BA51 |
potassium chloride, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12CA |
Sodium
|
Sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12CA01 |
sodium chloride
|
Chlorure de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12CA02 |
sodium sulfate
|
Sulfate de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12CB |
Zinc
|
Zinc
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12CB01 |
zinc sulfate
|
Sulfate de zinc
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12CB02 |
zinc gluconate
|
Gluconate de zinc
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12CC |
Magnesium
|
Magnésium
|
WHO |
Active |
2021-10-25 19:07:15 |
| A12CC01 |
magnesium chloride
|
Chlorure de magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12CC02 |
magnesium sulfate
|
Sulfate de magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12CC03 |
magnesium gluconate
|
Gluconate de magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12CC04 |
magnesium citrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12CC05 |
magnesium aspartate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12CC06 |
magnesium lactate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12CC07 |
magnesium levulinate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12CC08 |
magnesium pidolate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12CC09 |
magnesium orotate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12CC10 |
magnesium oxide
|
Oxyde de magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12CC30 |
magnesium (different salts in combination)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12CD |
Fluoride
|
Fluorure
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12CD01 |
sodium fluoride
|
Fluorure de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12CD02 |
sodium monofluorophosphate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12CD51 |
fluoride, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12CE |
Selenium
|
Sélénium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12CE01 |
sodium selenate
|
Sélénate de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A12CE02 |
sodium selenite
|
Sélénite de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
| A14AA |
Androstan derivatives
|
Dérivés de l'androstane
|
WHO |
Active |
2021-06-09 15:34:07 |
| A14AA01 |
androstanolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A14AA02 |
stanozolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A14AA03 |
metandienone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A14AA04 |
metenolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A14AA05 |
oxymetholone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A14AA06 |
quinbolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A14AA07 |
prasterone
|
Prastérone
|
WHO |
Active |
2021-06-09 15:34:07 |
| A14AA08 |
oxandrolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A14AA09 |
norethandrolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A14AB |
Estren derivatives
|
Dérivés de l'estrane
|
WHO |
Active |
2021-06-09 15:34:07 |
| A14AB01 |
nandrolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A14AB02 |
ethylestrenol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A14AB03 |
oxabolone cipionate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AA |
Amino acids and derivatives
|
Acides aminés et dérivés
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AA01 |
levocarnitine
|
Lévocarnitine
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AA02 |
ademetionine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AA03 |
glutamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AA04 |
mercaptamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AA05 |
carglumic acid
|
Acide carglumique
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AA06 |
betaine
|
Bétaïne
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AA07 |
metreleptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AB |
Enzymes
|
Enzymes
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AB01 |
alglucerase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AB02 |
imiglucerase
|
Imiglucérase
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AB03 |
agalsidase alfa
|
Agalsidase alfa
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AB04 |
agalsidase beta
|
Agalsidase bêta
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AB05 |
laronidase
|
Laronidase
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AB06 |
sacrosidase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AB07 |
alglucosidase alfa
|
Alglucosidase alfa
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AB08 |
galsulfase
|
Galsulfase
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AB09 |
idursulfase
|
Idursulfase
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AB10 |
velaglucerase alfa
|
Vélaglucérase Alfa
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AB11 |
taliglucerase alfa
|
Taliglucérase Alfa
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AB12 |
elosulfase alfa
|
Élosulfase Alfa
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AB13 |
asfotase alfa
|
ASFOTASE ALFA
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AB14 |
sebelipase alfa
|
Sébélipase alfa
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AB15 |
velmanase alfa
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AB16 |
idursulfase beta
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AB17 |
cerliponase alfa
|
Cerliponase Alfa
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AB18 |
vestronidase alfa
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AB19 |
pegvaliase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AX |
Various alimentary tract and metabolism products
|
Produits divers pour le tube digestif et le métabolisme
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AX01 |
thioctic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AX02 |
anethole trithione
|
Anéthole trithione
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AX03 |
sodium phenylbutyrate
|
Phénylbutyrate sodique
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AX04 |
nitisinone
|
Nitisinone
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AX05 |
zinc acetate
|
Acétate de Zinc
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AX06 |
miglustat
|
Miglustat
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AX07 |
sapropterin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AX08 |
teduglutide
|
TÉDUGLUTIDE
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AX09 |
glycerol phenylbutyrate
|
Phénylbutyrate de glycérol
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AX10 |
eliglustat
|
Éliglustat
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AX11 |
sodium benzoate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AX12 |
trientine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AX13 |
uridine triacetate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AX14 |
migalastat
|
Migalastat
|
WHO |
Active |
2021-06-09 15:34:07 |
| A16AX15 |
telotristat
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AA |
Vitamin K antagonists
|
Antivitamines K
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AA01 |
dicoumarol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AA02 |
phenindione
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AA03 |
warfarin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AA04 |
phenprocoumon
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AA07 |
acenocoumarol
|
Acénocoumarol
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AA08 |
ethyl biscoumacetate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AA09 |
clorindione
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AA10 |
diphenadione
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AA11 |
tioclomarol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AA12 |
fluindione
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AB |
Heparin group
|
Groupe de l'héparine
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AB01 |
heparin
|
Héparine
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AB02 |
antithrombin III
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AB04 |
dalteparin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AB05 |
Enoxaparin
|
Enoxaparine
|
WHO |
Active |
2021-10-01 12:48:37 |
| B01AB06 |
nadroparin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AB07 |
parnaparin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AB08 |
reviparin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AB09 |
danaparoid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AB10 |
tinzaparin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AB11 |
sulodexide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AB12 |
bemiparin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AB51 |
heparin, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AC |
Platelet aggregation inhibitors excl. heparin
|
Inhibiteurs de l'agrégation plaquettaire, héparine exclue
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AC01 |
ditazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AC02 |
cloricromen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AC03 |
picotamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AC04 |
clopidogrel
|
Clopidogrel
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AC05 |
ticlopidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AC06 |
acetylsalicylic acid
|
Acide acétylsalicylique
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AC07 |
dipyridamole
|
Dipyridamole
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AC08 |
carbasalate calcium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AC09 |
epoprostenol
|
Époprosténol
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AC10 |
indobufen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AC11 |
iloprost
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AC13 |
abciximab
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AC15 |
aloxiprin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AC16 |
eptifibatide
|
Eptifibatide
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AC17 |
tirofiban
|
Tirofiban
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AC18 |
triflusal
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AC19 |
beraprost
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AC21 |
treprostinil
|
Tréprostinil
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AC22 |
prasugrel
|
Prasugrel
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AC23 |
cilostazol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AC24 |
ticagrelor
|
Ticagrélor
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AC25 |
cangrelor
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AC26 |
vorapaxar
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AC27 |
selexipag
|
Sélexipag
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AC30 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AC56 |
acetylsalicylic acid, combinations with proton pump inhibitors
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AD |
Enzymes
|
Enzymes
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AD01 |
streptokinase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AD02 |
alteplase
|
Altéplase
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AD03 |
anistreplase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AD04 |
urokinase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AD05 |
fibrinolysin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AD06 |
brinase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AD07 |
reteplase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AD08 |
saruplase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AD09 |
ancrod
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AD10 |
drotrecogin alfa (activated)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AD11 |
tenecteplase
|
Ténectéplase
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AD12 |
protein C
|
Protéine c
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AE |
Direct thrombin inhibitors
|
Inhibiteurs directs de la thrombine
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AE01 |
desirudin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AE02 |
lepirudin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AE03 |
argatroban
|
Argatroban
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AE04 |
melagatran
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AE05 |
ximelagatran
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AE06 |
bivalirudin
|
Bivalirudine
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AE07 |
dabigatran etexilate
|
Dabigatran étexilate
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AF |
Direct factor Xa inhibitors
|
Inhibiteurs directs du facteur Xa
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AF01 |
rivaroxaban
|
Rivaroxaban
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AF02 |
apixaban
|
Apixaban
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AF03 |
edoxaban
|
Édoxaban
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AF04 |
betrixaban
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AX |
Other antithrombotic agents
|
Autres antithrombotiques
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AX01 |
defibrotide
|
DÉFIBROTIDE
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AX04 |
dermatan sulfate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AX05 |
fondaparinux
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B01AX07 |
caplacizumab
|
Caplacizumab
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02AA |
Amino acids
|
Acides aminés
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02AA01 |
aminocaproic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02AA02 |
tranexamic acid
|
Acide tranexamique
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02AA03 |
aminomethylbenzoic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02AB |
Proteinase inhibitors
|
Inhibiteurs de protéinases
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02AB01 |
aprotinin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02AB02 |
alfa1 antitrypsin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02AB04 |
camostat
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02AB05 |
ulinastatin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BA |
Vitamin K
|
Vitamine K
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BA01 |
phytomenadione
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BA02 |
menadione
|
Ménadione
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BB |
Fibrinogen
|
Fibrinogène
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BB01 |
fibrinogen, human
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BC |
Local hemostatics
|
Hémostatiques locaux
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BC01 |
absorbable gelatin sponge
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BC02 |
oxidized cellulose
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BC03 |
tetragalacturonic acid hydroxymethylester
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BC05 |
adrenalone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BC06 |
thrombin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BC07 |
collagen
|
Collagène
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BC08 |
calcium alginate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BC09 |
epinephrine
|
Épinéphrine
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BC30 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BD |
Blood coagulation factors
|
Facteurs de la coagulation sanguine
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BD01 |
coagulation factor IX, II, VII and X in combination
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BD02 |
coagulation factor VIII
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BD03 |
factor VIII inhibitor bypassing activity
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BD04 |
coagulation factor IX
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BD05 |
coagulation factor VII
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BD06 |
von Willebrand factor and coagulation factor VIII in combination
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BD07 |
coagulation factor XIII
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BD08 |
coagulation factor VIIa
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BD10 |
von Willebrand factor
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BD11 |
catridecacog
|
Catridecacog
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BD13 |
coagulation factor X
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BD14 |
susoctocog alfa
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BD30 |
thrombin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BX |
Other systemic hemostatics
|
Autres hémostatiques systémiques
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BX01 |
etamsylate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BX02 |
carbazochrome
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BX03 |
batroxobin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BX04 |
romiplostim
|
Romiplostim
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BX05 |
eltrombopag
|
Eltrombopag
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BX06 |
emicizumab
|
Émicizumab
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BX07 |
lusutrombopag
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BX08 |
avatrombopag
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B02BX09 |
fostamatinib
|
Fostamatinib
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03AA |
Iron bivalent, oral preparations
|
Fer bivalent, préparations orales
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03AA01 |
ferrous glycine sulfate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03AA02 |
ferrous fumarate
|
Fumarate ferreux
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03AA03 |
ferrous gluconate
|
Gluconate de fer
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03AA04 |
ferrous carbonate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03AA05 |
ferrous chloride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03AA06 |
ferrous succinate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03AA07 |
ferrous sulfate
|
Sulfate ferreux
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03AA08 |
ferrous tartrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03AA09 |
ferrous aspartate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03AA10 |
ferrous ascorbate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03AA11 |
ferrous iodine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03AA12 |
ferrous sodium citrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03AB |
Iron trivalent, oral preparations
|
Fer trivalent, préparations orales
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03AB01 |
ferric sodium citrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03AB02 |
saccharated iron oxide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03AB03 |
sodium feredetate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03AB04 |
ferric hydroxide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03AB05 |
ferric oxide polymaltose complexes
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03AB07 |
chondroitin sulfate-iron complex
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03AB08 |
ferric acetyl transferrin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03AB09 |
ferric proteinsuccinylate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03AB10 |
ferric maltol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03AD |
Iron in combination with folic acid
|
Fer en association avec l'acide folique
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03AD01 |
ferrous amino acid complex
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03AD02 |
ferrous fumarate
|
Fumarate ferreux
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03AD03 |
ferrous sulfate
|
Sulfate ferreux
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03AD04 |
ferric oxide polymaltose complexes
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03AE |
Iron in other combinations
|
Fer dans d'autres associations
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03AE01 |
iron, vitamin B12 and folic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03AE02 |
iron, multivitamins and folic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03AE03 |
iron and multivitamins
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03AE04 |
iron, multivitamins and minerals
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03AE10 |
various combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03BA |
Vitamin B12 (cyanocobalamin and analogues)
|
Vitamine B12 (cyanocobalamine et dérivés)
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03BA01 |
cyanocobalamin
|
Cyanocobalamine
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03BA02 |
cyanocobalamin tannin complex
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03BA03 |
hydroxocobalamin
|
Hydroxocobalamine
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03BA04 |
cobamamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03BA05 |
mecobalamin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03BA51 |
cyanocobalamin, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03BA53 |
hydroxocobalamin, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03BB |
Folic acid and derivatives
|
Acide folique et dérivés
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03BB01 |
folic acid
|
Acide folique
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03BB51 |
folic acid, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03XA |
Other antianemic preparations
|
Autres préparations anti-anémiques
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03XA01 |
erythropoietin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03XA02 |
darbepoetin alfa
|
Darbépoétine alfa
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03XA03 |
methoxy polyethylene glycol-epoetin beta
|
Méthoxy polyéthylèneglycol-époétine bêta
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03XA04 |
peginesatide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03XA05 |
roxadustat
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B03XA06 |
luspatercept
|
Luspatercept
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05AA |
Blood substitutes and plasma protein fractions
|
Substituts du sang et fractions protéiques plasmatiques
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05AA01 |
albumin
|
Albumine
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05AA02 |
other plasma protein fractions
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05AA03 |
fluorocarbon blood substitutes
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05AA05 |
dextran
|
Dextran
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05AA06 |
gelatin agents
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05AA07 |
hydroxyethylstarch
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05AA08 |
hemoglobin crosfumaril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05AA09 |
hemoglobin raffimer
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05AA10 |
hemoglobin glutamer (bovine)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05AX |
Other blood products
|
Autres dérivés du sang
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05AX02 |
thrombocytes
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05AX03 |
blood plasma
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05AX04 |
stem cells from umbilical cord blood
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05BA |
Solutions for parenteral nutrition
|
Solutions pour nutrition parentérale
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05BA01 |
amino acids
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05BA02 |
fat emulsions
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05BA03 |
carbohydrates
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05BA04 |
protein hydrolysates
|
Hydrolysat protéique
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05BA10 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05BB |
Solutions affecting the electrolyte balance
|
Solutions modifiant le bilan électrolytique
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05BB01 |
electrolytes
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05BB02 |
electrolytes with carbohydrates
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05BB03 |
trometamol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05BB04 |
electrolytes in combination with other drugs
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05BC |
Solutions producing osmotic diuresis
|
Solutions produisant une diurèse osmotique
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05BC01 |
mannitol
|
Mannitol
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05BC02 |
carbamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05CA |
Antiinfectives
|
Anti-infectieux
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05CA01 |
cetylpyridinium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05CA02 |
chlorhexidine
|
Chlorhexidine
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05CA03 |
nitrofural
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05CA04 |
sulfamethizole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05CA05 |
taurolidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05CA06 |
mandelic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05CA07 |
noxytiolin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05CA08 |
ethacridine lactate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05CA09 |
neomycin
|
Néomycine
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05CA10 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05CB |
Salt solutions
|
Solutions salines
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05CB01 |
sodium chloride
|
Chlorure de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05CB02 |
sodium citrate
|
Citrate de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05CB03 |
magnesium citrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05CB04 |
sodium bicarbonate
|
Bicarbonate de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05CB10 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05CX |
Other irrigating solutions
|
Autres solutions d'irrigation
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05CX01 |
glucose
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05CX02 |
sorbitol
|
Sorbitol
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05CX03 |
glycine
|
Glycine
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05CX04 |
mannitol
|
Mannitol
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05CX10 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05XA |
Electrolyte solutions
|
Solutions d'électrolytes
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05XA01 |
potassium chloride
|
Chlorure de potassium
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05XA02 |
sodium bicarbonate
|
Bicarbonate de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05XA03 |
sodium chloride
|
Chlorure de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05XA04 |
ammonium chloride
|
Chlorure d'ammonium
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05XA05 |
magnesium sulfate
|
Sulfate de magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05XA06 |
potassium phosphate, incl. combinations with other potassium salts
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05XA07 |
calcium chloride
|
Chlorure de calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05XA08 |
sodium acetate
|
Acétate de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05XA09 |
sodium phosphate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05XA10 |
magnesium phosphate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05XA11 |
magnesium chloride
|
Chlorure de magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05XA12 |
zinc chloride
|
Chlorure de zinc
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05XA13 |
hydrochloric acid
|
Acide chlorhydrique
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05XA14 |
sodium glycerophosphate
|
Glycérophosphate de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05XA15 |
potassium lactate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05XA16 |
cardioplegia solutions
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05XA17 |
potassium acetate
|
Acétate de potassium
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05XA30 |
combinations of electrolytes
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05XA31 |
electrolytes in combination with other drugs
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05XB |
Amino acids
|
Acides aminés
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05XB01 |
arginine hydrochloride
|
Chlorhydrate d'arginine
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05XB02 |
alanyl glutamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05XB03 |
lysine
|
Lysine
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05XX |
Other i.v. solution additives
|
Autres additifs pour solutions intraveineuses
|
WHO |
Active |
2021-06-09 15:34:07 |
| B05XX02 |
trometamol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B06AA |
Enzymes
|
Enzymes
|
WHO |
Active |
2021-06-09 15:34:07 |
| B06AA02 |
fibrinolysin and desoxyribonuclease
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B06AA03 |
hyaluronidase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B06AA04 |
chymotrypsin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B06AA07 |
trypsin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B06AA10 |
desoxyribonuclease
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B06AA55 |
streptokinase, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B06AB |
Heme products
|
Autres médicaments dérivés de l'hème
|
WHO |
Active |
2021-06-09 15:34:07 |
| B06AB01 |
hemin
|
Hémine
|
WHO |
Active |
2021-06-09 15:34:07 |
| B06AC |
Drugs used in hereditary angioedema
|
Autres médicaments utilisés dans l'angio-œdème héréditaire
|
WHO |
Active |
2021-06-09 15:34:07 |
| B06AC01 |
C1-inhibitor, plasma derived
|
Inhibiteurs C1, dérivés du plasma
|
WHO |
Active |
2021-10-01 12:48:41 |
| B06AC02 |
icatibant
|
ICATIBANT
|
WHO |
Active |
2021-06-09 15:34:07 |
| B06AC03 |
ecallantide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B06AC04 |
conestat alfa
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| B06AC05 |
lanadelumab
|
Lanadélumab
|
WHO |
Active |
2021-06-09 15:34:07 |
| B06AX |
Other hematological agents
|
Not found
|
WHO |
Active |
2021-06-09 15:34:07 |
| B06AX01 |
crizanlizumab
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01AA |
Digitalis glycosides
|
Glycosides de la Digitale
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01AA01 |
acetyldigitoxin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01AA02 |
acetyldigoxin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01AA03 |
digitalis leaves
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01AA04 |
digitoxin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01AA05 |
digoxin
|
Digoxine
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01AA06 |
lanatoside C
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01AA07 |
deslanoside
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01AA08 |
metildigoxin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01AA09 |
gitoformate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01AA52 |
acetyldigoxin, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01AB |
Scilla glycosides
|
Glycosides de la scille
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01AB01 |
proscillaridin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01AB51 |
proscillaridin, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01AC |
Strophanthus glycosides
|
Glycosides du Strophantus
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01AC01 |
g-strophanthin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01AC03 |
cymarin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01AX |
Other cardiac glycosides
|
Autres glycosides cardiotoniques
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01AX02 |
peruvoside
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01BA |
Antiarrhythmics, class Ia
|
Antiarythmiques, classe Ia
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01BA01 |
quinidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01BA02 |
procainamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01BA03 |
disopyramide
|
Disopyramide
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01BA04 |
sparteine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01BA05 |
ajmaline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01BA08 |
prajmaline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01BA12 |
lorajmine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01BA13 |
hydroquinidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01BA51 |
quinidine, combinations excl. psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01BA71 |
quinidine, combinations with psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01BB |
Antiarrhythmics, class Ib
|
Antiarythmiques, classe I
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01BB01 |
lidocaine
|
Lidocaïne
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01BB02 |
mexiletine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01BB03 |
tocainide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01BB04 |
aprindine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01BC |
Antiarrhythmics, class Ic
|
Antiarythmiques, classe
|
WHO |
Active |
2021-06-11 15:22:32 |
| C01BC03 |
propafenone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01BC04 |
flecainide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01BC07 |
lorcainide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01BC08 |
encainide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01BC09 |
ethacizine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01BD |
Antiarrhythmics, class III
|
Antiarythmiques, classe III
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01BD01 |
amiodarone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01BD02 |
bretylium tosilate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01BD03 |
bunaftine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01BD04 |
dofetilide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01BD05 |
ibutilide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01BD06 |
tedisamil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01BD07 |
dronedarone
|
Dronédarone
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01BG |
Other antiarrhythmics, class I and III
|
Autres antiarythmiques de classe I et III
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01BG01 |
moracizine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01BG07 |
cibenzoline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01BG11 |
vernakalant
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CA |
Adrenergic and dopaminergic agents
|
Agents adrénergiques et dopaminergique
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CA01 |
etilefrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CA02 |
isoprenaline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CA03 |
norepinephrine
|
Norépinéphrine
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CA04 |
dopamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CA05 |
norfenefrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CA06 |
phenylephrine
|
Phényléphrine
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CA07 |
dobutamine
|
Dobutamine
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CA08 |
oxedrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CA09 |
metaraminol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CA10 |
methoxamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CA11 |
mephentermine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CA12 |
dimetofrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CA13 |
prenalterol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CA14 |
dopexamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CA15 |
gepefrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CA16 |
ibopamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CA17 |
midodrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CA18 |
octopamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CA19 |
fenoldopam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CA21 |
cafedrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CA22 |
arbutamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CA23 |
theodrenaline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CA24 |
epinephrine
|
Épinéphrine
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CA25 |
amezinium metilsulfate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CA26 |
ephedrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CA27 |
droxidopa
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CA30 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CE |
Phosphodiesterase inhibitors
|
Inhibiteurs de la phosphodiestéra
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CE01 |
amrinone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CE02 |
milrinone
|
Milrinone
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CE03 |
enoximone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CE04 |
bucladesine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CX |
Other cardiac stimulants
|
Autres stimulants cardiaque
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CX06 |
angiotensinamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CX07 |
xamoterol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CX08 |
levosimendan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01CX09 |
angiotensin II
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DA |
Organic nitrates
|
Nitrates organiques
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DA02 |
glyceryl trinitrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DA04 |
methylpropylpropanediol dinitrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DA05 |
pentaerithrityl tetranitrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DA07 |
propatylnitrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DA08 |
isosorbide dinitrate
|
Dinitrate d'isosorbide
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DA09 |
trolnitrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DA13 |
eritrityl tetranitrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DA14 |
isosorbide mononitrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DA20 |
organic nitrates in combination
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DA38 |
tenitramine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DA52 |
glyceryl trinitrate, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DA55 |
pentaerithrityl tetranitrate, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DA58 |
isosorbide dinitrate, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DA70 |
organic nitrates in combination with psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DB |
Quinolone vasodilators
|
Vasodilateurs à base de quinolones
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DB01 |
flosequinan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DX |
Other vasodilators used in cardiac diseases
|
Autres vasodilateurs utilisés dans des maladies cardiaques
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DX01 |
itramin tosilate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DX02 |
prenylamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DX03 |
oxyfedrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DX04 |
benziodarone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DX05 |
carbocromen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DX06 |
hexobendine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DX07 |
etafenone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DX08 |
heptaminol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DX09 |
imolamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DX10 |
dilazep
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DX11 |
trapidil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DX12 |
molsidomine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DX13 |
efloxate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DX14 |
cinepazet
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DX15 |
cloridarol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DX16 |
nicorandil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DX18 |
linsidomine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DX19 |
nesiritide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DX21 |
serelaxin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DX52 |
prenylamine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01DX53 |
oxyfedrine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01EA |
Prostaglandins
|
Prostaglandines
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01EA01 |
alprostadil
|
Alprostadil
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01EB |
Other cardiac preparations
|
Autres médicaments pour le cœur
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01EB02 |
camphora
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01EB03 |
indometacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01EB04 |
crataegus glycosides
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01EB05 |
creatinolfosfate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01EB06 |
fosfocreatine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01EB07 |
fructose 1,6-diphosphate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01EB09 |
ubidecarenone
|
Ubidécarénone
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01EB10 |
adenosine
|
Adénosine
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01EB11 |
tiracizine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01EB13 |
acadesine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01EB15 |
trimetazidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01EB16 |
ibuprofen
|
Ibuprofène
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01EB17 |
ivabradine
|
Ivabradine
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01EB18 |
ranolazine
|
Ranolazine
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01EB21 |
regadenoson
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01EB22 |
meldonium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C01EB23 |
tiazotic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02AA |
Rauwolfia alkaloids
|
Alcaloïdes du Rauwolfia
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02AA01 |
rescinnamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02AA02 |
reserpine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02AA04 |
rauwolfia alkaloids, whole root
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02AA05 |
deserpidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02AA06 |
methoserpidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02AA07 |
bietaserpine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02AA52 |
reserpine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02AB |
Methyldopa
|
Méthyldopa
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02AB01 |
methyldopa (levorotatory)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02AB02 |
methyldopa (racemic)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02AC |
Imidazoline receptor agonists
|
Antagonistes des récepteurs de l'imidazoline
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02AC01 |
clonidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02AC02 |
guanfacine
|
Guanfacine
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02AC04 |
tolonidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02AC05 |
moxonidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02AC06 |
rilmenidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02BA |
Sulfonium derivatives
|
Dérivés du Sulfonium
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02BA01 |
trimetaphan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02BB |
Secondary and tertiary amines
|
Amines secondaires et tertiaires
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02BB01 |
mecamylamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02CA |
Alpha-adrenoreceptor antagonists
|
Alpha-bloquants
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02CA01 |
prazosin
|
Prazosine
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02CA02 |
indoramin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02CA03 |
trimazosin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02CA04 |
doxazosin
|
Doxazosine
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02CA06 |
urapidil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02CC |
Guanidine derivatives
|
Dérivés de la guanidine
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02CC01 |
betanidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02CC02 |
guanethidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02CC03 |
guanoxan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02CC04 |
debrisoquine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02CC05 |
guanoclor
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02CC06 |
guanazodine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02CC07 |
guanoxabenz
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02DA |
Thiazide derivatives
|
Dérivés du thiazide
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02DA01 |
diazoxide
|
Diazoxide
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02DB |
Hydrazinophthalazine derivatives
|
Dérivés de l'hydrazinophtalazine
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02DB01 |
dihydralazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02DB02 |
hydralazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02DB03 |
endralazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02DB04 |
cadralazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02DC |
Pyrimidine derivatives
|
Dérivés de la pyrimidine
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02DC01 |
minoxidil
|
Minoxidil
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02DD |
Nitroferricyanide derivatives
|
Dérivés du nitroferricyanure
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02DD01 |
nitroprusside
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02DG |
Guanidine derivatives
|
Dérivés de la guanidine
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02DG01 |
pinacidil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02KA |
Alkaloids, excl. rauwolfia
|
Alcaloïdes, autres que ceux du Rauwolfia
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02KA01 |
veratrum
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02KB |
Tyrosine hydroxylase inhibitors
|
Inhibiteurs de la tyrosine hydroxylase
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02KB01 |
metirosine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02KC |
MAO inhibitors
|
IMAO, inhibiteurs de la monoamino oxydase
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02KC01 |
pargyline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02KD |
Serotonin antagonists
|
Antagonistes de la sérotonine
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02KD01 |
ketanserin
|
Kétansérine
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02KX |
Antihypertensives for pulmonary arterial hypertension
|
Antihypertenseurs pour l'hypertension artérielle pulmonaire
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02KX01 |
bosentan
|
Bosentan
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02KX02 |
ambrisentan
|
Ambrisentan
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02KX03 |
sitaxentan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02KX04 |
macitentan
|
MACITENTAN
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02KX05 |
riociguat
|
RIOCIGUAT
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02KX52 |
ambrisentan and tadalafil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02LA |
Rauwolfia alkaloids and diuretics in combination
|
Associations d'alcaloïdes du Rauwolfia et de diurétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02LA01 |
reserpine and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02LA02 |
rescinnamine and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02LA03 |
deserpidine and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02LA04 |
methoserpidine and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02LA09 |
syrosingopine and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02LA50 |
combination of rauwolfia alkaloids and diuretics incl. other combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02LA51 |
reserpine and diuretics, combinations with other drugs
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02LA52 |
rescinnamine and diuretics, combinations with other drugs
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02LA71 |
reserpine and diuretics, combinations with psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02LB |
Methyldopa and diuretics in combination
|
Associations de méthyldopa et de diurétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02LB01 |
methyldopa (levorotatory) and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02LC |
Imidazoline receptor agonists in combination with diuretics
|
Associations d'antagonistes des récepteurs de l'imidazoline et de diurétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02LC01 |
clonidine and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02LC05 |
moxonidine and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02LC51 |
clonidine and diuretics, combinations with other drugs
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02LE |
Alpha-adrenoreceptor antagonists and diuretics
|
Associations d'alpha-bloquants et de diurétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02LE01 |
prazosin and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02LF |
Guanidine derivatives and diuretics
|
Associations de dérivés de la guanidine et de diurétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02LF01 |
guanethidine and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02LG |
Hydrazinophthalazine derivatives and diuretics
|
Associations de dérivés de la hydrazinophtalazine et de diurétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02LG01 |
dihydralazine and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02LG02 |
hydralazine and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02LG51 |
dihydralazine and diuretics, combinations with other drugs
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02LL |
MAO inhibitors and diuretics
|
Associations d'IMAO et de diurétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
| C02LL01 |
pargyline and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03AA |
Thiazides, plain
|
Thiazidiques non associés
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03AA01 |
bendroflumethiazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03AA02 |
hydroflumethiazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03AA03 |
hydrochlorothiazide
|
Hydrochlorothiazide
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03AA04 |
chlorothiazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03AA05 |
polythiazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03AA06 |
trichlormethiazide
|
Trichlorméthiazide
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03AA07 |
cyclopenthiazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03AA08 |
methyclothiazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03AA09 |
cyclothiazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03AA13 |
mebutizide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03AB |
Thiazides and potassium in combination
|
Thiazidiques et potassium en association
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03AB01 |
bendroflumethiazide and potassium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03AB02 |
hydroflumethiazide and potassium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03AB03 |
hydrochlorothiazide and potassium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03AB04 |
chlorothiazide and potassium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03AB07 |
cyclopenthiazide and potassium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03AB09 |
cyclothiazide and potassium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03AH |
Thiazides, combinations with psycholeptics and/or analgesics
|
Thiazidiques en association avec psycholeptiques et/ou analgésiques
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03AH02 |
hydroflumethiazide, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03AX |
Thiazides, combinations with other drugs
|
Thiazidiques en association avec d'autres substances
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03AX01 |
hydrochlorothiazide, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03BA |
Sulfonamides, plain
|
Sulfamides non associés
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03BA02 |
quinethazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03BA03 |
clopamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03BA04 |
chlortalidone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03BA05 |
mefruside
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03BA07 |
clofenamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03BA08 |
metolazone
|
Métolazone
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03BA09 |
meticrane
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03BA10 |
xipamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03BA11 |
indapamide
|
Indapamide
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03BA12 |
clorexolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03BA13 |
fenquizone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03BB |
Sulfonamides and potassium in combination
|
Sulfamides et potassium en association
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03BB03 |
clopamide and potassium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03BB04 |
chlortalidone and potassium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03BC |
Mercurial diuretics
|
Diurétiques mercuriels
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03BC01 |
mersalyl
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03BD |
Xanthine derivatives
|
Dérivés xanthiques
|
WHO |
Active |
2021-10-25 19:07:17 |
| C03BD01 |
theobromine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03BX |
Other low-ceiling diuretics
|
Autres diurétiques low-ceiling
|
WHO |
Active |
2021-10-25 19:07:19 |
| C03BX03 |
cicletanine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03CA |
Sulfonamides, plain
|
Sulfamides non associés
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03CA01 |
furosemide
|
Furosémide
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03CA02 |
bumetanide
|
Bumétanide
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03CA03 |
piretanide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03CA04 |
torasemide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03CB |
Sulfonamides and potassium in combination
|
Sulfamides et potassium en association
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03CB01 |
furosemide and potassium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03CB02 |
bumetanide and potassium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03CC |
Aryloxyacetic acid derivatives
|
Dérivés de l'acide aryloxyacétique
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03CC01 |
etacrynic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03CC02 |
tienilic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03CD |
Pyrazolone derivatives
|
Dérivés de la pyrazolone
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03CD01 |
muzolimine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03CX |
Other high-ceiling diuretics
|
Autres diurétiques de l'anse
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03CX01 |
etozolin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
| C03DA |
Aldosterone antagonists
|
Antagonistes de l'aldostérone
|
WHO |
